Country

bionomics-and-ctx-reach-proof-of-concept-milestone-in-the-discovery-and-preclinical-evaluation-of-ctx-0357927-which-suppresses-cancer-progression

Bionomics, CTx advance in growth factor research

  • Australia
  • |
  • News

Singapore: Bionomics joint program with the Australian Partner consortium Co-operative Research Centre for Cancer Therapeutics (CTx) has reached a proof of concept milestone in the discovery and preclinical evaluation of inhibitors of vascular... Read more

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone... Read more

awak-technologies-bags-singapore-innovation-enterprise-award

Awak wins NUS award for 'wearable' artificial kidney...


  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Singapore-based Awak Technologies has bagged Promising NUS Start-up Award at Innovation & Enterprise (I&E) Awards... Read more

mr-tatsuya-kimura-drug-information-association-japan

Tatsuya Kimura: Japan is a steadily growing market

  • Japan
  • |
  • Opinion
  • |
  • By Mr Tatsuya Kimura
  • |
  • 0 Comment

The Asian business strategy of multinational pharmaceutical companies in terms of resource reallocation and investment will become a key... Read more

taiwan-implemented-policies-in-2012-that-indicate-its-seriousness-towards-elevating-its-bioscience-industry

Taiwan: Fosters global partnerships

  • Taiwan
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

A small island country, Taiwan, has implemented policies that indicate its seriousness towards elevating its bioscience industry. Recently,... Read more

south-korea-s-biotechnology-is-strengthening-its-r-d-capacity-in-genomics-proteomics-and-bioinformatics

South Korea: Strengthens position using clinical research

  • Korea
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 1 Comment

The year 2012 has been particularly eventful for South Korea. Not only has the nation elected its first woman president, Ms Park Geun-hye,... Read more

singapore-continues-to-enhance-its-biomedical-sciences-cluster

Singapore: Rides the medtech wave

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 1 Comment

With an aim to become the number 1 hotspot for global bioscience industry in Asia, Singapore has committed $13.05 billion (S$16.1 billion)... Read more

ranbaxy-has-been-hit-hard-by-the-gavel

Ranbaxy pleads guilty, will pay $500 mn to the US

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: Ranbaxy Laboratories has reached a final settlement agreement regarding a previously disclosed investigation by the US Department... Read more

malaysia-is-emerging-as-a-bioscience-hub-for-international-life-science-companies-by-providing-them-smooth-passage-to-set-up-manufacturing-plants

Malaysia: Emerges as a manufacturing hub

  • Malaysia
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Malaysia is now emerging as a manufacturing hub for international pharmaceutical companies and provides them smooth passage to set up manufacturing... Read more

indian-life-science-is-leveraging-on-increasing-sales-of-generic-medicines-continued-growth-in-chronic-therapies-and-greater-penetration-in-rural-markets

India: Policy reforms enables bioscience sector

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Leveraging on the back of increasing sales of generic medicines, continued growth in chronic therapies and a greater penetration in rural... Read more

in-late-2012-the-national-development-and-reform-commission-ndrc-of-china-announced-a-new-price-cut-policy-for-pharmaceuticals-effective-from-february-1-2013

China: Shines despite slower pace of growth

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the country in its 12th... Read more

the-australian-government-is-under-pressure-to-offer-drugs-at-affordable-prices-and-to-lower-cost-of-healthcare

Australia: Controls healthcare cost, drives market

  • Australia
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X